BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19973420)

  • 41. Erythropoietin responsiveness in polycythaemia vera.
    Golde DW; Cline MJ
    Br J Haematol; 1975 Apr; 29(4):567-73. PubMed ID: 1191565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythroid colony formation in primary proliferative polycythaemia, idiopathic erythrocytosis and secondary polycythaemia: sensitivity to erythropoietic stimulating factors.
    Eridani S; Pearson TC; Sawyer B; Batten E; Wetherley-Mein G
    Clin Lab Haematol; 1983; 5(2):121-9. PubMed ID: 6603955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Megakaryocytic colony formation in polycythaemia vera and secondary erythrocytosis.
    Juvonen E; Partanen S; Ikkala E; Ruutu T
    Br J Haematol; 1988 Aug; 69(4):441-4. PubMed ID: 3408680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripheral blood lymphocyte subpopulations in patients with primary proliferative and secondary polycythaemia.
    Wilde JT; Barnett D; Forrest MJ; Lawrence AC
    J Clin Pathol; 1987 Feb; 40(2):206-9. PubMed ID: 2950138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secondary polycythaemia in chronic respiratory insufficiency.
    Vanuxem D; Guillot C; Fornaris E; Weiller PJ; Grimaud C
    Thorax; 1977 Jun; 32(3):317-21. PubMed ID: 882946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. THe dynamics of erythropoiesis inhibition in posttransfusion polycythaemia in the rat.
    Goralska M
    Acta Physiol Pol; 1977; 28(4):321-8. PubMed ID: 596181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zinc status in polycythaemia.
    Simmer K; Pearson TC; Wheeler MJ; Thompson RP
    Eur J Haematol; 1987 May; 38(5):433-6. PubMed ID: 3653365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 125I fibrinogen turnover in polycythaemia: the effect of phlebotomy.
    Boughton BJ; Dallinger KJ
    Br J Haematol; 1983 Jan; 53(1):97-102. PubMed ID: 6848130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Polycythaemia and uterine fibroma. A case with in vitro demonstration of an erythropoietic activity in the tumor (author's transl)].
    Desablens B; Steenkiste G; Boffa GA; Messerschmitt J
    Sem Hop; 1980 Jun 18-25; 56(25-28):1138-44. PubMed ID: 6256861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common immunophenotype.
    Neilson JR; Patton WN; Williams MD; Mayne EE; Boughton BJ
    J Clin Pathol; 1994 May; 47(5):471-2. PubMed ID: 8027406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol.
    Bhatia S; Kaur P; Kaur G; Tahlan A; Saini V; Bedi R; Mittal K; Sood T
    Transfus Clin Biol; 2023 Feb; 30(1):63-68. PubMed ID: 35835318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials.
    Mazza GL; Mead-Harvey C; Mascarenhas J; Yacoub A; Kosiorek HE; Hoffman R; Dueck AC; Mesa RA;
    Lancet Haematol; 2022 Jan; 9(1):e38-e48. PubMed ID: 34971581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global REACH 2018: the adaptive phenotype to life with chronic mountain sickness and polycythaemia.
    Hansen AB; Moralez G; Amin SB; Simspon LL; Hofstaetter F; Anholm JD; Gasho C; Stembridge M; Dawkins TG; Tymko MM; Ainslie PN; Villafuerte F; Romero SA; Hearon CM; Lawley JS
    J Physiol; 2021 Sep; 599(17):4021-4044. PubMed ID: 34245004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
    Squizzato A; Romualdi E; Passamonti F; Middeldorp S
    Cochrane Database Syst Rev; 2013 Apr; (4):CD006503. PubMed ID: 23633335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medullary nephrocalcinosis, distal renal tubular acidosis and polycythaemia in a patient with nephrotic syndrome.
    Karunarathne S; Udayakumara Y; Govindapala D; Fernando H
    BMC Nephrol; 2012 Jul; 13():66. PubMed ID: 22834973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Characteristics of diagnostic approach to erythrocytosis of different genesis].
    Ter Arkh; 2012; 84(4):29-35. PubMed ID: 22774487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
    Squizzato A; Romualdi E; Middeldorp S
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006503. PubMed ID: 18425953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Polycythaemia vera--diagnosis and therapy].
    Lechner K; Geissler K; Gisslinger H
    Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bilateral renal vein thrombosis due to inapparent polycythaemia.
    Rapur R; Gudithi S; Adiraju KP; Vangipurapu Rangacharlu S; Venkata DK
    NDT Plus; 2011 Aug; 4(4):244-5. PubMed ID: 25949491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secondary polycythaemia associated with high plasma erythropoietin concentrations in a dog with a necrotising pyelonephritis.
    Kessler M
    J Small Anim Pract; 2008 Jul; 49(7):363-6. PubMed ID: 18482331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.